194 related articles for article (PubMed ID: 23486417)
1. Vaccination of piglets up to 1 week of age with a single-dose Mycoplasma hyopneumoniae vaccine induces protective immunity within 2 weeks against virulent challenge in the presence of maternally derived antibodies.
Wilson S; Van Brussel L; Saunders G; Runnels P; Taylor L; Fredrickson D; Salt J
Clin Vaccine Immunol; 2013 May; 20(5):720-4. PubMed ID: 23486417
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight.
Wilson S; Van Brussel L; Saunders G; Taylor L; Zimmermann L; Heinritzi K; Ritzmann M; Banholzer E; Eddicks M
Vaccine; 2012 Dec; 30(52):7625-9. PubMed ID: 23084853
[TBL] [Abstract][Full Text] [Related]
3. Effect of sow vaccination against Mycoplasma hyopneumoniae on sow and piglet colonization and seroconversion, and pig lung lesions at slaughter.
Sibila M; Bernal R; Torrents D; Riera P; Llopart D; Calsamiglia M; Segalés J
Vet Microbiol; 2008 Feb; 127(1-2):165-70. PubMed ID: 17826008
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.
Michiels A; Arsenakis I; Boyen F; Krejci R; Haesebrouck F; Maes D
BMC Vet Res; 2017 Aug; 13(1):274. PubMed ID: 28851359
[TBL] [Abstract][Full Text] [Related]
5. Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains.
Villarreal I; Vranckx K; Calus D; Pasmans F; Haesebrouck F; Maes D
BMC Vet Res; 2012 Jan; 8():2. PubMed ID: 22225838
[TBL] [Abstract][Full Text] [Related]
6. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.
Martelli P; Saleri R; Cavalli V; De Angelis E; Ferrari L; Benetti M; Ferrarini G; Merialdi G; Borghetti P
Vet Microbiol; 2014 Jan; 168(2-4):357-64. PubMed ID: 24332702
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
[TBL] [Abstract][Full Text] [Related]
8. Oral vaccination of piglets against Mycoplasma hyopneumoniae using silica SBA-15 as an adjuvant effectively reduced consolidation lung lesions at slaughter.
Mechler-Dreibi ML; Almeida HMS; Sonalio K; Martines MAC; Petri FAM; Zambotti BB; Ferreira MM; Storino GY; Martins TS; Montassier HJ; Sant'Anna OA; Fantini MCA; de Oliveira LG
Sci Rep; 2021 Nov; 11(1):22377. PubMed ID: 34789792
[TBL] [Abstract][Full Text] [Related]
9. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
Park SJ; Seo HW; Park C; Chae C
Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
[TBL] [Abstract][Full Text] [Related]
10. Local and systemic immune responses in pigs intramuscularly injected with an inactivated Mycoplasma hyopneumoniae vaccine.
Marchioro SB; Maes D; Flahou B; Pasmans F; Del Pozo Sacristán R; Vranckx K; Melkebeek V; Cox E; Wuyts N; Haesebrouck F
Vaccine; 2013 Feb; 31(9):1305-11. PubMed ID: 23306368
[TBL] [Abstract][Full Text] [Related]
11. Maternal immunity enhances Mycoplasma hyopneumoniae vaccination induced cell-mediated immune responses in piglets.
Bandrick M; Theis K; Molitor TW
BMC Vet Res; 2014 Jun; 10():124. PubMed ID: 24903770
[TBL] [Abstract][Full Text] [Related]
12. Effect of vaccination of pigs against experimental infection with high and low virulence Mycoplasma hyopneumoniae strains.
Villarreal I; Maes D; Vranckx K; Calus D; Pasmans F; Haesebrouck F
Vaccine; 2011 Feb; 29(9):1731-5. PubMed ID: 21237277
[TBL] [Abstract][Full Text] [Related]
13. Effect of cross-fostering on transfer of maternal immunity to Mycoplasma hyopneumoniae to piglets.
Bandrick M; Pieters M; Pijoan C; Baidoo SK; Molitor TW
Vet Rec; 2011 Jan; 168(4):100. PubMed ID: 21493469
[TBL] [Abstract][Full Text] [Related]
14. Vaccination inhibits TLR2 transcription via suppression of GR nuclear translocation and binding to TLR2 promoter in porcine lung infected with Mycoplasma hyopneumoniae.
Sun Z; Liu M; Zou H; Li X; Shao G; Zhao R
Vet Microbiol; 2013 Dec; 167(3-4):425-33. PubMed ID: 24035265
[TBL] [Abstract][Full Text] [Related]
15. Antibody response to Mycoplasma hyopneumoniae infection in vaccinated pigs with or without maternal antibodies induced by sow vaccination.
Martelli P; Terreni M; Guazzetti S; Cavirani S
J Vet Med B Infect Dis Vet Public Health; 2006 Jun; 53(5):229-33. PubMed ID: 16732881
[TBL] [Abstract][Full Text] [Related]
16. Reduced lung lesions in pigs challenged 25 weeks after the administration of a single dose of Mycoplasma hyopneumoniae vaccine at approximately 1 week of age.
Reynolds SC; St Aubin LB; Sabbadini LG; Kula J; Vogelaar J; Runnels P; Peters AR
Vet J; 2009 Sep; 181(3):312-20. PubMed ID: 18554964
[TBL] [Abstract][Full Text] [Related]
17. Application of a sIgA-ELISA method for differentiation of Mycoplasma hyopneumoniae infected from vaccinated pigs.
Bai Y; Gan Y; Hua LZ; Nathues H; Yang H; Wei YN; Wu M; Shao GQ; Feng ZX
Vet Microbiol; 2018 Sep; 223():86-92. PubMed ID: 30173757
[TBL] [Abstract][Full Text] [Related]
18. [Vaccination of sows against Mycoplasma hyopneumoniae with Hyoresp].
Grosse Beilage E; Schreiber A
Dtsch Tierarztl Wochenschr; 2005 Jul; 112(7):256-61. PubMed ID: 16124699
[TBL] [Abstract][Full Text] [Related]
19. Effects of Mycoplasma hyopneumoniae vaccine on pigs naturally infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome virus.
Moreau IA; Miller GY; Bahnson PB
Vaccine; 2004 Jun; 22(17-18):2328-33. PubMed ID: 15149792
[TBL] [Abstract][Full Text] [Related]
20. Comparison of transmission of Mycoplasma hyopneumoniae in vaccinated and non-vaccinated populations.
Meyns T; Dewulf J; de Kruif A; Calus D; Haesebrouck F; Maes D
Vaccine; 2006 Nov; 24(49-50):7081-6. PubMed ID: 16934376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
